KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q1 2021 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI) Q1 2021 Results Earnings Conference Call May 03, 2021, 08:30 AM ET Company Participants Ian Karp - Senior Vice President, Investor and Public Relations Richard Paulson - President and Chief Executive Officer Michael Kauffman - Co-Founder, Senior Clinical Advisor and Board Member Michael Mason - Chief Financial Officer John Demaree - Chief Commercial Officer Stephen Mitchener - Chief Business Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Maury Raycroft - Jefferies Peter Lawson - Barclays Eric Joseph - JPMorgan David Lebowitz - Morgan Stanley Jonathan Chang - SVB Leerink Ed White - H.C. Wainwright Colleen Kusy - Baird Arlinda Lee - Canaccord Presentation Operator Good morning. My name is Jason, and I will be your conference operator for today. At this time, I’d like to welcome everyone to Karyopharm Therapeutics' First Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to
For further details see:
Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q1 2021 Results - Earnings Call Transcript